Eden Research (LON:EDEN) Hits New 52-Week Low – Time to Sell?

Posted by Bonnie Powley on Mar 19th, 2025

Eden Research plc (LON:EDEN – Get Free Report) shares hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 2.90 ($0.04) and last traded at GBX 2.90 ($0.04), with a volume of 258375 shares changing hands. The stock had previously closed at GBX 2.95 ($0.04).

Eden Research Price Performance

The stock has a 50-day moving average price of GBX 3.59 and a two-hundred day moving average price of GBX 3.81. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a market cap of £15.47 million, a price-to-earnings ratio of -10.16 and a beta of 0.92.

Insiders Place Their Bets

In other news, insider Alexander John Abrey bought 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($28,109.20). Also, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,312.53). Over the last 90 days, insiders acquired 964,487 shares of company stock valued at $3,690,001. 14.02% of the stock is currently owned by corporate insiders.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.